although treatment with ganciclovir may be associated with marrow suppression , the serious nature of gastrointestinal infection due to cytomegalovirus in the immunocompromised host , the antiviral effect and the possible clinical improvement observed in vivo , and the lack of other effective treatments justify further controlled studies with this agent in immunocompromised patients with serious cytomegalovirus infection .
C0017066
ganciclovir
C0010823
cytomegalovirus infection